DOCSLIB.ORG

Mouse Cog5 Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Cog5 Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Cog5 Knockout Project (CRISPR/Cas9) Objective: To create a Cog5 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Cog5 gene (NCBI Reference Sequence: NM_001163126 ; Ensembl: ENSMUSG00000035933 ) is located on Mouse chromosome 12. 23 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 22 (Transcript: ENSMUST00000036862). Exon 2~5 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 2 starts from about 3.82% of the coding region. Exon 2~5 covers 12.99% of the coding region. The size of effective KO region: ~9669 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 23 Legends Exon of mouse Cog5 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 2 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of Exon 5 is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Page 3 of 9 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(28.25% 565) | C(19.4% 388) | T(33.9% 678) | G(18.45% 369) Note: The 2000 bp section upstream of Exon 2 is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(20.05% 401) | C(25.5% 510) | T(34.8% 696) | G(19.65% 393) Note: The 2000 bp section downstream of Exon 5 is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 9 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr12 + 31658718 31660717 2000 browser details YourSeq 97 1374 1517 2000 93.8% chr2 - 128994437 128994611 175 browser details YourSeq 94 1412 1518 2000 95.3% chr17 - 21529744 21529865 122 browser details YourSeq 90 1412 1516 2000 94.3% chr19 + 47335979 47336275 297 browser details YourSeq 87 1412 1518 2000 94.9% chr8 - 108979636 108979757 122 browser details YourSeq 86 1412 1516 2000 92.4% chr12 - 118723100 118723219 120 browser details YourSeq 86 1412 1518 2000 91.6% chr14 + 50769801 50769922 122 browser details YourSeq 85 1412 1517 2000 93.0% chr11 - 95949822 95949942 121 browser details YourSeq 84 1412 1518 2000 92.1% chr12 - 34293154 34293275 122 browser details YourSeq 84 1412 1517 2000 95.7% chr15 + 94157907 94158027 121 browser details YourSeq 82 1411 1516 2000 92.8% chr2 - 37836109 37836223 115 browser details YourSeq 81 1191 1517 2000 95.6% chr4 - 34770630 34771020 391 browser details YourSeq 81 1412 1517 2000 94.7% chr4 + 134176611 134176722 112 browser details YourSeq 81 1412 1517 2000 96.7% chr11 + 51798430 51798550 121 browser details YourSeq 80 1412 1517 2000 96.6% chr9 - 116978226 116978347 122 browser details YourSeq 80 1412 1518 2000 91.8% chr19 - 5614655 5614776 122 browser details YourSeq 80 1412 1516 2000 91.0% chr18 - 57987210 57987329 120 browser details YourSeq 80 1412 1516 2000 90.9% chr13 - 46901613 46901731 119 browser details YourSeq 80 1414 1517 2000 91.7% chr10 - 120808099 120808219 121 browser details YourSeq 80 1412 1516 2000 90.0% chr18 + 20016498 20016616 119 Note: The 2000 bp section upstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr12 + 31670387 31672386 2000 browser details YourSeq 893 467 1998 2000 87.6% chr5 + 108221667 108223152 1486 browser details YourSeq 443 149 1345 2000 83.3% chr9 - 49480812 49481935 1124 browser details YourSeq 396 1239 1949 2000 83.2% chr14 + 31674651 31675342 692 browser details YourSeq 390 57 879 2000 85.9% chr15 - 98236819 98237675 857 browser details YourSeq 368 770 1932 2000 86.8% chr12 - 32265541 32266737 1197 browser details YourSeq 362 912 1950 2000 83.9% chr17 + 24825776 24826772 997 browser details YourSeq 347 165 1221 2000 84.0% chr3 - 99674784 99675799 1016 browser details YourSeq 337 83 996 2000 84.8% chr10 + 97853613 97854546 934 browser details YourSeq 319 1093 1922 2000 83.8% chr18 - 13555074 13555861 788 browser details YourSeq 314 83 918 2000 81.4% chr9 + 54791579 54792427 849 browser details YourSeq 309 1202 1962 2000 80.1% chr13 - 29139720 29140252 533 browser details YourSeq 308 1288 1963 2000 81.5% chr8 - 65200694 65201353 660 browser details YourSeq 298 1317 1952 2000 81.4% chr8 - 91266268 91266902 635 browser details YourSeq 294 976 1954 2000 83.9% chr1 - 194843616 194844486 871 browser details YourSeq 294 959 1951 2000 80.5% chr18 + 7699576 7700529 954 browser details YourSeq 291 183 895 2000 82.5% chr6 - 147782129 147782815 687 browser details YourSeq 286 316 992 2000 85.9% chr4 - 14059436 14060500 1065 browser details YourSeq 284 132 658 2000 83.4% chr4 - 98251927 98252465 539 browser details YourSeq 278 45 724 2000 82.5% chr1 + 65305672 65306321 650 Note: The 2000 bp section downstream of Exon 5 is BLAT searched against the genome. No significant similarity is found. Page 5 of 9 https://www.alphaknockout.com Gene and protein information: Cog5 component of oligomeric golgi complex 5 [ Mus musculus (house mouse) ] Gene ID: 238123, updated on 12-Aug-2019 Gene summary Official Symbol Cog5 provided by MGI Official Full Name component of oligomeric golgi complex 5 provided by MGI Primary source MGI:MGI:2145130 See related Ensembl:ENSMUSG00000035933 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as GTC90; C87247; D18362; GOLTC1; 5430405C01Rik Expression Ubiquitous expression in ovary adult (RPKM 11.7), mammary gland adult (RPKM 11.4) and 28 other tissues See more Orthologs human all Genomic context Location: 12; 12 A2-A3 See Cog5 in Genome Data Viewer Exon count: 25 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 12 NC_000078.6 (31654819..31937630) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 12 NC_000078.5 (32339734..32622495) Chromosome 12 - NC_000078.6 Page 6 of 9 https://www.alphaknockout.com Transcript information: This gene has 4 transcripts Gene: Cog5 ENSMUSG00000035933 Description component of oligomeric golgi complex 5 [Source:MGI Symbol;Acc:MGI:2145130] Gene Synonyms 5430405C01Rik, GOLTC1, GTC90 Location Chromosome 12: 31,654,869-31,937,630 forward strand. GRCm38:CM001005.2 About this gene This gene has 4 transcripts (splice variants), 215 orthologues and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Cog5- ENSMUST00000036862.4 2997 829aa ENSMUSP00000044797.4 Protein coding CCDS49046 Q8C0L8 TSL:1 201 GENCODE basic APPRIS P1 Cog5- ENSMUST00000218428.1 3610 99aa ENSMUSP00000151730.1 Protein coding - A0A1W2P7M6 CDS 5' 202 incomplete TSL:3 Cog5- ENSMUST00000219837.1 372 21aa ENSMUSP00000151902.1 Nonsense mediated - A0A1W2P822 CDS 5' 204 decay incomplete TSL:5 Cog5- ENSMUST00000219672.1 750 No - Retained intron - - TSL:2 203 protein Page 7 of 9 https://www.alphaknockout.com 302.76 kb Forward strand 31.7Mb 31.8Mb 31.9Mb Genes (Comprehensive set... Cog5-201 >protein coding Gm48808-201 >processed pseudogene Gm25913-201 >scaRNA Cog5-202 >protein coding Gm18029-201 >processed pseudogene Cog5-204 >nonsense mediated decay Cog5-203 >retained intron Contigs AC119950.14 > AC125020.7 > CT010463.9 > Genes < Dus4l-201protein coding < Gpr22-201protein coding < Gm48809-201lncRNA < Hbp1-207retained intron (Comprehensive set... < Dus4l-202lncRNA < Gpr22-204protein coding < Hbp1-203retained intron < Dus4l-203lncRNA < Gpr22-203protein coding < Hbp1-202protein coding < Gpr22-202protein coding < Hbp1-201protein coding < Hbp1-209protein coding < Hbp1-204protein coding < Hbp1-208protein coding < Hbp1-206protein coding < Hbp1-205protein coding Regulatory Build 31.7Mb 31.8Mb 31.9Mb Reverse strand 302.76 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Non-Protein Coding RNA gene pseudogene processed transcript Page 8 of 9 https://www.alphaknockout.com Transcript: ENSMUST00000036862 282.76 kb Forward strand Cog5-201 >protein coding ENSMUSP00000044... Low complexity (Seg) Pfam Conserved oligomeric Golgi complex subunit 5 PANTHER Conserved oligomeric Golgi complex subunit 5 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 80 160 240 320 400 480 560 640 720 829 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 9 of 9.
Load more

Recommended publications
  • Congenital Disorders of Glycosylation from a Neurological Perspective
    brain sciences Review Congenital Disorders of Glycosylation from a Neurological Perspective Justyna Paprocka 1,* , Aleksandra Jezela-Stanek 2 , Anna Tylki-Szyma´nska 3 and Stephanie Grunewald 4 1 Department of Pediatric Neurology, Faculty of Medical Science in Katowice, Medical University of Silesia, 40-752 Katowice, Poland 2 Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland; [email protected] 3 Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, W 04-730 Warsaw, Poland; [email protected] 4 NIHR Biomedical Research Center (BRC), Metabolic Unit, Great Ormond Street Hospital and Institute of Child Health, University College London, London SE1 9RT, UK; [email protected] * Correspondence: [email protected]; Tel.: +48-606-415-888 Abstract: Most plasma proteins, cell membrane proteins and other proteins are glycoproteins with sugar chains attached to the polypeptide-glycans. Glycosylation is the main element of the post- translational transformation of most human proteins. Since glycosylation processes are necessary for many different biological processes, patients present a diverse spectrum of phenotypes and severity of symptoms. The most frequently observed neurological symptoms in congenital disorders of glycosylation (CDG) are: epilepsy, intellectual disability, myopathies, neuropathies and stroke-like episodes. Epilepsy is seen in many CDG subtypes and particularly present in the case of mutations
    [Show full text]
  • Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024
    Document downloaded from http://www.elsevier.es, day 26/09/2021. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Nº Ref Uniprot Proteína Péptidos identificados 1 P01024 CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 por 162MS/MS 2 P02751 FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 131 3 P01023 A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 128 4 P0C0L4 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 95 5 P04275 VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 81 6 P02675 FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 78 7 P01031 CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 66 8 P02768 ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 66 9 P00450 CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 64 10 P02671 FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 58 11 P08603 CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 56 12 P02787 TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 54 13 P00747 PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 48 14 P02679 FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 47 15 P01871 IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 41 16 P04003 C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 37 17 Q9Y6R7 FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 30 18 O43866 CD5L_HUMAN CD5 antigen-like OS=Homo
    [Show full text]
  • The Untold Stories of the Speech Gene, the FOXP2 Cancer Gene
    www.Genes&Cancer.com Genes & Cancer, Vol. 9 (1-2), January 2018 The untold stories of the speech gene, the FOXP2 cancer gene Maria Jesus Herrero1,* and Yorick Gitton2,* 1 Center for Neuroscience Research, Children’s National Medical Center, NW, Washington, DC, USA 2 Sorbonne University, INSERM, CNRS, Vision Institute Research Center, Paris, France * Both authors contributed equally to this work Correspondence to: Yorick Gitton, email: [email protected] Keywords: FOXP2 factor, oncogene, cancer, prognosis, language Received: March 01, 2018 Accepted: April 02, 2018 Published: April 18, 2018 Copyright: Herrero and Gitton et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT FOXP2 encodes a transcription factor involved in speech and language acquisition. Growing evidence now suggests that dysregulated FOXP2 activity may also be instrumental in human oncogenesis, along the lines of other cardinal developmental transcription factors such as DLX5 and DLX6 [1–4]. Several FOXP family members are directly involved during cancer initiation, maintenance and progression in the adult [5–8]. This may comprise either a pro- oncogenic activity or a deficient tumor-suppressor role, depending upon cell types and associated signaling pathways. While FOXP2 is expressed in numerous cell types, its expression has been found to be down-regulated in breast cancer [9], hepatocellular carcinoma [8] and gastric cancer biopsies [10]. Conversely, overexpressed FOXP2 has been reported in multiple myelomas, MGUS (Monoclonal Gammopathy of Undetermined Significance), several subtypes of lymphomas [5,11], as well as in neuroblastomas [12] and ERG fusion-negative prostate cancers [13].
    [Show full text]
  • Cog5–Cog7 Crystal Structure Reveals Interactions Essential for the Function of a Multisubunit Tethering Complex
    Cog5–Cog7 crystal structure reveals interactions essential for the function of a multisubunit tethering complex Jun Yong Haa, Irina D. Pokrovskayab, Leslie K. Climerb, Gregory R. Shimamuraa, Tetyana Kudlykb, Philip D. Jeffreya, Vladimir V. Lupashinb,c, and Frederick M. Hughsona,1 aDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544; bDepartment of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72205; and cBiological Institute, Tomsk State University, Tomsk, 634050, Russian Federation Edited by Thomas C. Südhof, Stanford University School of Medicine, Stanford, CA, and approved September 30, 2014 (received for review August 4, 2014) The conserved oligomeric Golgi (COG) complex is required, along have been structurally characterized to date (11, 14). Defining the with SNARE and Sec1/Munc18 (SM) proteins, for vesicle docking quaternary structure of the other CATCHR-family MTCs remains and fusion at the Golgi. COG, like other multisubunit tethering a major challenge. complexes (MTCs), is thought to function as a scaffold and/or The COG complex is an MTC that is essential for vesicle chaperone to direct the assembly of productive SNARE complexes transport within the Golgi apparatus and from endosomal com- at the sites of membrane fusion. Reflecting this essential role, partments to the Golgi (3). Defects in individual COG subunits mutations in the COG complex can cause congenital disorders of can lead to the aberrant distribution of glycosylation enzymes glycosylation. A deeper understanding of COG function and dys- within the Golgi and thereby to severe genetic diseases known as function will likely depend on elucidating its molecular structure. congenital disorders of glycosylation (CDGs) (17, 18).
    [Show full text]
  • Simpintlists Package
    simpIntLists Package May 20, 2021 R topics documented: simpIntLists-package . .1 ArabidopsisBioGRIDInteractionEntrezId . .4 ArabidopsisBioGRIDInteractionOfficial . .6 ArabidopsisBioGRIDInteractionUniqueId . .7 C.ElegansBioGRIDInteractionEntrezId . .9 C.ElegansBioGRIDInteractionOfficial . 11 C.ElegansBioGRIDInteractionUniqueId . 13 findInteractionList . 14 FruitFlyBioGRIDInteractionEntrezId . 16 FruitFlyBioGRIDInteractionOfficial . 18 FruitFlyBioGRIDInteractionUniqueId . 19 HumanBioGRIDInteractionEntrezId . 21 HumanBioGRIDInteractionOfficial . 22 HumanBioGRIDInteractionUniqueId . 23 MouseBioGRIDInteractionEntrezId . 24 MouseBioGRIDInteractionOfficial . 25 MouseBioGRIDInteractionUniqueId . 27 S.PombeBioGRIDInteractionEntrezId . 28 S.PombeBioGRIDInteractionOfficial . 30 S.PombeBioGRIDInteractionUniqueId . 33 YeastBioGRIDInteractionEntrezId . 35 YeastBioGRIDInteractionOfficial . 38 YeastBioGRIDInteractionUniqueId . 41 Index 46 simpIntLists-package The package contains BioGRID interactions for various organ- isms in a simple format Description The package contains BioGRID interactions for arabidopsis(thale cress), c.elegans, fruit fly, human, mouse, yeast( budding yeast ) and S.pombe (fission yeast) . Entrez ids, official names and unique ids can be used to find proteins. 1 2 simpIntLists-package Details simpIntLists-package 3 Package: simpIntLists Type: Package Version: 1.0 Date: 2011-01-18 License: GPL version 2 or newer LazyLoad: yes Author(s) Kircicegi KORKMAZ, Volkan ATALAY, Rengul CETIN ATALAY Maintainer: Kircicegi KORKMAZ <[email protected]> References
    [Show full text]
  • Prior Infection with Type a Francisella Tularensis Antagonizes The
    Walters et al. BMC Genomics (2015) 16:874 DOI 10.1186/s12864-015-2022-2 RESEARCH ARTICLE Open Access Prior infection with Type A Francisella tularensis antagonizes the pulmonary transcriptional response to an aerosolized Toll-like receptor 4 agonist Kathie-Anne Walters1*, Rachael Olsufka2, Rolf E. Kuestner1, Xiagang Wu1, Kai Wang1, Shawn J. Skerrett2 and Adrian Ozinsky1 Abstract Background: Francisella infection attenuates immune cell infiltration and expression of selected pro-inflammatory cytokines in response to endogenous LPS, suggesting the bacteria is actively antagonizing at least some part of the response to Toll-like receptor 4 (TLR4) engagement. The ability of different Francisella strains to inhibit the ability of E. coli LPS to induce a pulmonary inflammatory response, as measured by gene expression profiling, was examined to define the scope of modulation and identify of inflammatory genes/pathways that are specifically antagonized by a virulent F. tularensis infection. Results: Prior aerosol exposure to F. tularensis subsp. tularensis, but not the live attenuated strain (LVS) of F. tularensis subsp. holarctica or F. novicida, significantly antagonized the transcriptional response in the lungs of infected mice exposed to aerosolized E. coli LPS. The response to E. coli LPS was not completely inhibited, suggesting that the bacteria is targeting further downstream of the TLR4 molecule. Analysis of the promotors of LPS-responsive genes that were perturbed by Type A Francisella infection identified candidate transcription factors that were potentially modulated by the bacteria, including multiple members of the forkhead transcription factor family (FoxA1, Foxa2, FoxD1, Foxd3, Foxf2, FoxI1, Fox03, Foxq1), IRF1, CEBPA, and Mef2. The annotated functional roles of the affected genes suggested that virulent Francisella infection suppressed cellular processes including mRNA processing, antiviral responses, intracellular trafficking, and regulation of the actin cytoskeleton.
    [Show full text]
  • COG5 Variants Lead to Complex Early Onset Retinal Degeneration
    www.nature.com/scientificreports OPEN COG5 variants lead to complex early onset retinal degeneration, upregulation of PERK and DNA damage Sami Tabbarah1,2,3,4, Erika Tavares2, Jason Charish3, Ajoy Vincent1,2, Andrew Paterson2, Matteo Di Scipio2, Yue Yin2, Roberto Mendoza‑Londono5, Jason Maynes6,7, Elise Heon1,2,8* & Philippe P. Monnier1,3,4,8* Leber congenital amaurosis (LCA), a form of autosomal recessive severe early‑onset retinal degeneration, is an important cause of childhood blindness. This may be associated with systemic features or not. Here we identifed COG5 compound‑heterozygous variants in patients afected with a complex LCA phenotype associated with microcephaly and skeletal dysplasia. COG5 is a component of the COG complex, which facilitates retrograde Golgi trafcking; if disrupted this can result in protein misfolding. To date, variants in COG5 have been associated with a distinct congenital disorder of glycosylation (type IIi) and with a variant of Friedreich’s ataxia. We show that COG5 variants can also result in fragmentation of the Golgi apparatus and upregulation of the UPR modulator, PKR‑ like endoplasmic reticulum kinase (PERK). In addition, upregulation of PERK induces DNA damage in cultured cells and in murine retina. This study identifes a novel role for COG5 in maintaining ER protein homeostasis and that disruption of that role results in activation of PERK and early‑onset retinal degeneration, microcephaly and skeletal dysplasia. These results also highlight the importance of the UPR pathway in early‑onset retinal dystrophy and as potential therapeutic targets for patients. Severe retinal degeneration (RD) with early-onset and nystagmus is ofen referred to as Leber’s congenital amau- rosis (LCA), which is a genetically heterogeneous form of inherited retinal disease (IRD)1 for which gene-specifc treatments have been initiated2.
    [Show full text]
  • Gnomad Lof Supplement
    1 gnomAD supplement gnomAD supplement 1 Data processing 4 Alignment and read processing 4 Variant Calling 4 Coverage information 5 Data processing 5 Sample QC 7 Hard filters 7 Supplementary Table 1 | Sample counts before and after hard and release filters 8 Supplementary Table 2 | Counts by data type and hard filter 9 Platform imputation for exomes 9 Supplementary Table 3 | Exome platform assignments 10 Supplementary Table 4 | Confusion matrix for exome samples with Known platform labels 11 Relatedness filters 11 Supplementary Table 5 | Pair counts by degree of relatedness 12 Supplementary Table 6 | Sample counts by relatedness status 13 Population and subpopulation inference 13 Supplementary Figure 1 | Continental ancestry principal components. 14 Supplementary Table 7 | Population and subpopulation counts 16 Population- and platform-specific filters 16 Supplementary Table 8 | Summary of outliers per population and platform grouping 17 Finalizing samples in the gnomAD v2.1 release 18 Supplementary Table 9 | Sample counts by filtering stage 18 Supplementary Table 10 | Sample counts for genomes and exomes in gnomAD subsets 19 Variant QC 20 Hard filters 20 Random Forest model 20 Features 21 Supplementary Table 11 | Features used in final random forest model 21 Training 22 Supplementary Table 12 | Random forest training examples 22 Evaluation and threshold selection 22 Final variant counts 24 Supplementary Table 13 | Variant counts by filtering status 25 Comparison of whole-exome and whole-genome coverage in coding regions 25 Variant annotation 30 Frequency and context annotation 30 2 Functional annotation 31 Supplementary Table 14 | Variants observed by category in 125,748 exomes 32 Supplementary Figure 5 | Percent observed by methylation.
    [Show full text]
  • Novel Compound Heterozygous COG5 Mutations in a Chinese Male Patient with Severe Clinical Symptoms and Type Iii Congenital Disorder of Glycosylation: a Case Report
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 18: 2695-2700, 2019 Novel compound heterozygous COG5 mutations in a Chinese male patient with severe clinical symptoms and type IIi congenital disorder of glycosylation: A case report SHAOWEI YIN1-3, LIYING GONG4, HAO QIU5, YAN ZHAO6, YAN ZHANG7, CAIXIA LIU1-3, HONGKUN JIANG8, YAN MAO5, LING-YIN KONG5, BO LIANG9 and YUAN LV1-3 1Liaoning Centre for Prenatal Diagnosis, Key Laboratory of Maternal-Fetal Medicine of Liaoning Province; 2Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province; 3Department of Obstetrics and Gynecology, Shengjing Hospital Affiliated to China Medical University, Shenyang, Liaoning 110004; 4Clinical Laboratory, The People's Hospital of China Medical University, Shenyang, Liaoning 110016; 5Basecare Medical Device Co., Ltd., Suzhou, Jiangsu 215000; 6Genetics Unit; 7The Outpatient Department of Obstetrics, Shenyang Maternity and Infant's Hospital, Shenyang, Liaoning 110004; 8Department of Pediatrics, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110016; 9State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, P.R. China Received November 30, 2018; Accepted July 5, 2019 DOI: 10.3892/etm.2019.7834 Abstract. In the current study, one case of COG5-CDG Introduction involving a Chinese male patient with severe neurological symptoms, who had previously been misdiagnosed with Mutations in subunit five of the conserved oligomeric Golgi congenital gyrus malformation, is described. A clinical investi- (COG) complex gives rise to type IIi congenital disorders of gation was performed and targeted next-generation sequencing glycosylation (CDG) (1). CDG is physiologically related to (NGS) was used to identify COG5 variants in the patient and other pathologies involving glycan defects and can lead to his family.
    [Show full text]
  • Genetic Association of GDF5, COG5 and CYBA Gene Polymorphisms
    Research Article iMedPub Journals Genetics and Molecular Biology Research 2018 http://www.imedpub.com/ Vol.1 No.1:5 Genetic Association of GDF5, COG5 and CYBA Gene Polymorphisms with Primary Knee Osteoarthritis in South Indian Population 1* Poornima S1 , Subramanyam K2, Khan IA3, Sumanlatha G4 , Hasan Q 1Department of Genetics and Molecular Medicine, Kamineni Hospitals, Hyderabad, Telangana, India. 2Department of Orthopedics, Yashoda Hospitals, Hyderabad, Telangana, India. 3Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia. 4Department of Genetics, Osmania University, Hyderabad, Telangana, India. *Corresponding author: Dr. Qurratulain Hasan, Department of Genetics & Molecular Medicine, Kamineni Hospitals, LB Nagar, Hyderabad 500068, India, Tel: 040-39879999; E-mail: [email protected] Received date: February 24, 2018; Accepted date: March 22, 2017; Published date: April 03, 2018 Copyright: © 2018 Poornima S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. the disability caused by the disease. To the best of our knowledge this is the first study in India. Abstract Purpose: Osteoarthritis (OA) is also known as degenerative Keywords: Osteoarthritis; GDF5; COG5; CYBA; South arthritis and it affects millions of people and can have a Indian population huge impact on their lives.
    [Show full text]
  • An Integrated Framework for Genome Analysis Reveals Numerous Previously
    bioRxiv preprint doi: https://doi.org/10.1101/563270; this version posted February 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. An Integrated Framework for Genome Analysis Reveals Numerous Previously Unrecognizable Structural Variants in Leukemia Patients’ Samples Jie Xu1*, Fan Song1,6*, Emily Schleicher1*, Christopher Pool3, Darrin Bann3, Max Hennessy3, Kathryn Sheldon2, Emma Batchelder2, Charyguly Annageldiyev4, Arati Sharma4, Yuanyuan Chang7, Alex Hastie7, Barbara Miller5, David Goldenberg3, Shin Mineishi5, David Claxton4, George-Lucian Moldovan1, Feng Yue1,2, James R. Broach1,2 1 Department of Biochemistry and 2 Institute for Personalized Medicine Penn State College of Medicine, Hershey, PA 17033 3 Department of Otolaryngology, 4 Department of Hematology Oncology, 5Departments of Pediatrics and Medicine PennState Health, Hershey Medical Center, Hershey, PA 17033 6 Huck Institute of Life Sciences, Penn State University, State College, PA 16802 7 Bionano Genomics, 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121 *Contributed equally to the project. Corresponding author: James R. Broach [email protected] 717-531-8586 Running title: Novel leukemia structural variants 1 bioRxiv preprint doi: https://doi.org/10.1101/563270; this version posted February 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Key Words: Acute myeloid leukemia Somatic mutation Genomic structural variants Optical mapping Karyotyping Chromothripsis Allelic imbalance Patient outcomes 2 bioRxiv preprint doi: https://doi.org/10.1101/563270; this version posted February 28, 2019.
    [Show full text]
  • Chromosome-Specific and Global Effects of Aneuploidy in Saccharomyces Cerevisiae
    Genetics: Early Online, published on February 2, 2016 as 10.1534/genetics.115.185660 Chromosome-Specific and Global Effects of Aneuploidy in Saccharomyces cerevisiae Stacie E. Dodgson*,†, Sharon Kim*,†, Michael Costanzo‡, Anastasia Baryshnikova§, Darcy L. Morse†, Chris A. Kaiser†, Charles Boone‡, Angelika Amon*,† * Koch Institute for Integrative Cancer Research, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA † Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA ‡ The Donnelly Centre, University of Toronto, Toronto, ON M5S3E1, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S3E1, Canada § Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544-1014 1 Copyright 2016. Aneuploidy Synthetic Interactions Keywords: aneuploidy, synthetic lethality, dosage imbalance, protein transport Corresponding author: Angelika Amon, 77 Massachusetts Avenue 76-561, Cambridge, MA 02139; 617-258-6559; [email protected] 2 ABSTRACT Aneuploidy, an unbalanced karyotype in which one or more chromosomes are present in excess or reduced copy number, causes an array of known phenotypes including proteotoxicity, genomic instability and slowed proliferation. However, the molecular consequences of aneuploidy are poorly understood and an unbiased investigation into aneuploid cell biology is lacking. We performed high-throughput screens for genes whose deletion has a synthetic fitness cost in aneuploid Saccharomyces cerevisiae cells containing single extra chromosomes. This analysis identified genes that when deleted decrease the fitness of specific disomic strains as well as those that impair the proliferation of a broad range of aneuploidies. In one case, a chromosome-specific synthetic growth defect could be explained fully by the specific duplication of a single gene on the aneuploid chromosome, highlighting the ability of individual dosage imbalances to cause chromosome-specific phenotypes in aneuploid cells.
    [Show full text]